Elevated GPER expression is strongly associated with reduced relapse-free survival (RFS) and distant metastasis-free survival (DMFS), especially in patients with additional risk factors such as lymph node metastasis (LNM), high tumor grade (G3), and advanced TNM stage (309). The gene discussed is GPER1; the disease is neoplasm.